ADL
TCRT icon

Asset Dedication LLC’s Alaunos Therapeutics TCRT Stock Holding History

Asset Dedication LLC’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-46
Closed -$111 – 1172
2025
Q3 		$111 Hold
46
– – ﹤0.01% 1127
2025
Q2 		$224 Sell
46
-8
-15% -$24 ﹤0.01% 1150
2025
Q1 		$80 Hold
54
– – ﹤0.01% 1115
2024
Q4 		$103 Hold
54
– – ﹤0.01% 1079
2024
Q3 		$174 Sell
54
-1
-2% -$4 ﹤0.01% 1125
2024
Q2 		$385 Buy
+55
New +$656 ﹤0.01% 1147
2024
Q1 		– Sell
-55
Closed – – 1042
2023
Q4 		$0 Hold
55
– – ﹤0.01% 1055
2023
Q3 		$1K Hold
55
– – ﹤0.01% 962
2023
Q2 		$5K Hold
55
– – ﹤0.01% 783
2023
Q1 		$5K Hold
55
– – ﹤0.01% 763
2022
Q4 		$6K Hold
55
– – ﹤0.01% 729
2022
Q3 		$14K Hold
55
– – ﹤0.01% 579
2022
Q2 		$11K Hold
55
– – ﹤0.01% 340
2022
Q1 		$6K Hold
55
– – ﹤0.01% 731
2021
Q4 		$9K Hold
55
– – ﹤0.01% 663
2021
Q3 		$15K Buy
55
+47
+588% +$14.4K ﹤0.01% 630
2021
Q2 		$3K Buy
+8
New +$3.73K ﹤0.01% 768
2018
Q2 		– Sell
-1
Closed – – 743
2018
Q1 		$0 Buy
+1
New +$623 ﹤0.01% 558

Other funds holding TCRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Asset Dedication LLC's TCRT Position: Q4 2025 in Review

Asset Dedication LLC sold out of Alaunos Therapeutics (TCRT) in Q4 2025, closing a stake of 46 shares — an estimated $111 sold.

Asset Dedication LLC first reported a position in TCRT in Q1 2018 and held it in 18 quarters. The position peaked at $15K in Q3 2021. 27 funds tracked by Wall St. Rank hold TCRT as of Q4 2025.

  • Asset Dedication LLC reported no remaining Alaunos Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Asset Dedication LLC sold 46 Alaunos Therapeutics shares in Q4 2025, an estimated $111.
  • Asset Dedication LLC first reported a position in Alaunos Therapeutics in Q1 2018 and held it in 18 quarters.
  • Asset Dedication LLC's Alaunos Therapeutics position peaked at $15K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2025.

Based on Asset Dedication LLC's 13F filing for Q4 2025, filed 26 Jan 2026.